Antibacterial Potential of Lactobacillus-Derived Bacteriocin-Like Inhibitory Substances (BLIS) Against Group B Streptococcus (GBS): A Biotherapeutic Approach
2025African Journal of Clinical Medicine and Pharmacy ResearchJournalOpen access
10.58578/ajcmpr.v2i2.5387Full text0 citations